Trevor A Seeger1, Adam Kirton1, Michael J Esser2, Clare Gallagher1, Jeff Dunn1, Ephrem Zewdie1, Omar Damji3, Patrick Ciechanski1, Karen M Barlow4. 1. Cumming School of Medicine, University of Calgary, Calgary, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, Canada; Alberta Children's Hospital Research Institute, Alberta Children's Hospital, Calgary, Canada. 2. Cumming School of Medicine, University of Calgary, Calgary, Canada; Alberta Children's Hospital Research Institute, Alberta Children's Hospital, Calgary, Canada. 3. Cumming School of Medicine, University of Calgary, Calgary, Canada. 4. Cumming School of Medicine, University of Calgary, Calgary, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, Canada; Alberta Children's Hospital Research Institute, Alberta Children's Hospital, Calgary, Canada. Electronic address: karen.barlow@albertahealthservices.ca.
Abstract
INTRODUCTION:Mild traumatic brain injury (mTBI) outcomes are variable, and 10-15% may suffer from prolonged symptoms beyond 3 months that impair the child's return to normal activities. Neurophysiological mechanisms of mTBI are incompletely understood, particularly in children, but alterations in cortical excitability have been proposed to underlie post-concussion syndrome. Improved understanding is required to advance interventions and improve outcomes. OBJECTIVE/HYPOTHESIS: To determine if cortical excitability is altered in children with mTBI, and its association with clinical symptoms. METHODS: This was a cross-sectional controlled cohort study. School-aged children (8-18 years) with mTBI were compared to healthy controls. Cortical excitability was measured using multiple TMS paradigms in children with (symptomatic) and without (recovered) persistent symptoms one-month post-injury. Primary outcome was the cortical silent period (cSP), a potential neurophysiological biomarker of GABAergic inhibition. Secondary outcomes included additional TMS neurophysiology, safety and tolerability. Associations between neurophysiology parameters and clinical symptoms were evaluated. RESULTS:Fifty-three children with mTBI (55% male; mean age 14.1 SD: 2.4 years; 35 symptomatic and 27 asymptomatic participants) and 28 controls (46% male; mean age 14.3 SD: 3.1 years) were enrolled. cSP duration was similar between groups (F (2, 73) = 0.55, p = 0.582). Log10 long interval intracortical inhibition (LICI) was reduced in symptomatic participants compared to healthy controls (F (2, 59) = 3.83, p = 0.027). Procedures were well tolerated with no serious adverse events. CONCLUSIONS:TMS measures of cortical excitability are altered at one month in children with mTBI. Long interval cortical inhibition is decreased in children who remain symptomatic at one month post-injury. Copyright Â
RCT Entities:
INTRODUCTION: Mild traumatic brain injury (mTBI) outcomes are variable, and 10-15% may suffer from prolonged symptoms beyond 3 months that impair the child's return to normal activities. Neurophysiological mechanisms of mTBI are incompletely understood, particularly in children, but alterations in cortical excitability have been proposed to underlie post-concussion syndrome. Improved understanding is required to advance interventions and improve outcomes. OBJECTIVE/HYPOTHESIS: To determine if cortical excitability is altered in children with mTBI, and its association with clinical symptoms. METHODS: This was a cross-sectional controlled cohort study. School-aged children (8-18 years) with mTBI were compared to healthy controls. Cortical excitability was measured using multiple TMS paradigms in children with (symptomatic) and without (recovered) persistent symptoms one-month post-injury. Primary outcome was the cortical silent period (cSP), a potential neurophysiological biomarker of GABAergic inhibition. Secondary outcomes included additional TMS neurophysiology, safety and tolerability. Associations between neurophysiology parameters and clinical symptoms were evaluated. RESULTS: Fifty-three children with mTBI (55% male; mean age 14.1 SD: 2.4 years; 35 symptomatic and 27 asymptomatic participants) and 28 controls (46% male; mean age 14.3 SD: 3.1 years) were enrolled. cSP duration was similar between groups (F (2, 73) = 0.55, p = 0.582). Log10 long interval intracortical inhibition (LICI) was reduced in symptomatic participants compared to healthy controls (F (2, 59) = 3.83, p = 0.027). Procedures were well tolerated with no serious adverse events. CONCLUSIONS: TMS measures of cortical excitability are altered at one month in children with mTBI. Long interval cortical inhibition is decreased in children who remain symptomatic at one month post-injury. Copyright Â
Authors: Colin K Franz; Divya Joshi; Elizabeth L Daley; Rogan A Grant; Kyriakos Dalamagkas; Audrey Leung; John D Finan; Evangelos Kiskinis Journal: J Neurophysiol Date: 2019-05-22 Impact factor: 2.714
Authors: Andrew R Mayer; Mayank Kaushal; Andrew B Dodd; Faith M Hanlon; Nicholas A Shaff; Rebekah Mannix; Christina L Master; John J Leddy; David Stephenson; Christopher J Wertz; Elizabeth M Suelzer; Kristy B Arbogast; Timothy B Meier Journal: Neurosci Biobehav Rev Date: 2018-08-09 Impact factor: 8.989
Authors: William Stokes; Keith Runnalls; Jake Choynowki; Maria St Pierre; Manuel Anaya; Matthew A Statton; Pablo A Celnik; Gabriela Cantarero Journal: J Neurophysiol Date: 2020-02-19 Impact factor: 2.714
Authors: Parmis Fatih; M Utku Kucuker; Jennifer L Vande Voort; Deniz Doruk Camsari; Faranak Farzan; Paul E Croarkin Journal: Front Psychiatry Date: 2021-06-02 Impact factor: 4.157
Authors: Mitchell B Locke; Stephen L Toepp; Claudia V Turco; Diana H Harasym; Michel P Rathbone; Michael D Noseworthy; Aimee J Nelson Journal: Clin Neurophysiol Pract Date: 2020-08-06